Mesoblast Ltd ADR (NASDAQ:MESO)’s traded shares stood at 0.44 million during the last session, with the company’s beta value hitting 3.46. At the close of trading, the stock’s price was $10.81, to imply an increase of 13.19% or $1.26 in intraday trading. The MESO share’s 52-week high remains $9.76, putting it 9.71% up since that peak but still an impressive 85.11% since price per share fell to its 52-week low of $1.61. The company has a valuation of $1.23B, with an average of 0.22 million shares in intraday trading volume over the past 10 days and average of 167.90K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Mesoblast Ltd ADR (MESO), translating to a mean rating of 1.00. Of 10 analyst(s) looking at the stock, 2 analyst(s) give MESO a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.35.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mesoblast Ltd ADR (NASDAQ:MESO) trade information
After registering a 13.19% upside in the last session, Mesoblast Ltd ADR (MESO) has traded red over the past five days. The 5-day price performance for the stock is 42.24%, and 68.64% over 30 days. With these gigs, the year-to-date price performance is 391.36%. Short interest in Mesoblast Ltd ADR (NASDAQ:MESO) saw shorts transact 1.01 million shares and set a 8.98 days time to cover.
The extremes give us $11 and $12 for target low and target high price respectively. As such, MESO has been trading -11.01% off suggested target high and -1.76% from its likely low.
Mesoblast Ltd ADR (MESO) estimates and forecasts
Looking at statistics comparing Mesoblast Ltd ADR share performance against respective industry, we note that the company has underperformed competitors. Mesoblast Ltd ADR (MESO) shares are 86.38% up over the last 6 months, with its year-to-date growth rate lower than industry average at 16.85% against 17.60%. The rating firms project that company’s revenue will grow 125.20% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is 13.29M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 3.86M.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 12.34% for the past 5-year period. While 2024 is set for a 36.03% return in earnings, projections for the next 5 years are at 48.80% annually.
MESO Dividends
Mesoblast Ltd ADR has its next earnings report out on 2024-Aug-28. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
